Literature DB >> 190216

Cardiac adenosine 3':5'-monophosphate. Free and bound forms in the isolated rat atrium.

W L Terasaki, G Brooker.   

Abstract

Adenosine 3':5'-monophosphate (cyclic AMP), a mediator of hormone action in a variety of tissues, has been measured in its free and bound forms in intact cardiac tissue. We have used a rapid high dilution technique which involves tissue homogenization, subcellular fractionation, and separation of bound from free cyclic AMP by Millopore filtration. The precision of this method is dependent upon minimization of binding and dissociation of cyclic AMP that occur during the preparation and handling of tissue homogenates. In each experiment, a tracer of cyclic [3H]AMP prebound to isolated cardiac binding protein was freed of unbound cyclic [3H]AMP by Sephadex gel filtration and added to the tissue just prior to homogenization in cold EDTA buffer. This tracer was therefore treated identically to the sample through all subsequent dilution, fractionation, and filtration procedures, and provided an acurate internal monitor for total cyclic AMP dissociation during the course of the free-bound determination. Each tissue sample was then individually corrected for dissociation. Rapid dilution to produce a 1:1000 homogenate was found to lower endogenous cyclic AMP levels sufficiently to make binding (or rebinding) during the procedure negligible (less than 5%). Spontaneously beating rat right atria (controls) contained 5.96 +/- 0.28 pmol of cyclic AMP/mg of protein (n = 19) of which 41 and 14% were bound to soluble and particulate proteins, respectively. The remaining cyclic AMP was free. Pretreatment of the tissue with 1 muM isoproterenol (30 s at 30 degrees) increased both the bound and free forms of cyclic AMP (n = 8). While free cyclic AMP increased 420% with the catecholamine, the bound forms increased 240% (soluble) and 60% (particulate). Similar results were obtained when atria (n = 6) were treated with the phosphodiesterase inhibitor, methylisobutylxanthine (0.5 mM, 10 min at 30 degrees). When both agents were used together, cyclic AMP bound to soluble proteins was elevated 4-fold over control while free cyclic AMP increased 27-fold (n = 7), indicating saturation of the soluble sites. It could be calculated that less than one-third of these sites are occupied in the unstimulated cell. These sites may represent the R subunit of cyclic AMP-dependent protein kinase. The data suggest that half-maximal binding in vivo occurs at an intracellular free cyclic AMP concentration of about 1 muM.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 190216

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Cellular site and state combination of the adenosine 3':5'-cyclic monophosphate persisting after excitation of cerebral tissues.

Authors:  M Newman; H McIlwain
Journal:  Biochem J       Date:  1978-01-15       Impact factor: 3.857

2.  Protein kinases A and C regulate receptor-mediated increases in cAMP in rabbit erythrocytes.

Authors:  Shaquria P Adderley; Meera Sridharan; Elizabeth A Bowles; Alan H Stephenson; Mary L Ellsworth; Randy S Sprague
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

3.  Effects of several phosphodiesterase-inhibitors on guinea-pig myocardium.

Authors:  M Korth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-03       Impact factor: 3.000

4.  Cyclic AMP binding proteins and cyclic AMP-dependent protein kinase from Blastocladiella emersonii.

Authors:  P M Silverman
Journal:  J Bacteriol       Date:  1978-09       Impact factor: 3.490

5.  Induction of cyclic AMP phosphodiesterase in Blastocladiella emersonii and its relation to cyclic AMP metabolism.

Authors:  P M Epstein; P M Silverman
Journal:  J Bacteriol       Date:  1978-09       Impact factor: 3.490

6.  Adenosine 3':5'-cyclic monophosphate-dependent protein kinase(s) of rat ovarian cells. Gonadotropin regulation of adenosine 3':5'-cyclic monophosphate-receptor activity.

Authors:  K M Menon; S Azhar
Journal:  Biochem J       Date:  1978-06-15       Impact factor: 3.857

7.  Olfactory adenylate cyclase of the rat. Stimulation by odorants and inhibition by Ca2+.

Authors:  S G Shirley; C J Robinson; K Dickinson; R Aujla; G H Dodd
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

8.  Isoprenaline-like effects of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine on mechanical, biochemical and electrophysiological parameters in the mammalian heart.

Authors:  R Brückner; S Gramann; M Nose; W Schmitz; H Scholz
Journal:  Experientia       Date:  1985-06-15

9.  UD-CG 115--a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle.

Authors:  P Honerjäger; A Heiss; M Schäfer-Korting; G Schönsteiner; M Reiter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

10.  Does activation of cyclic AMP dependent phosphorylation induced by beta-adrenergic agent control the tone of vascular muscle?

Authors:  M Hirata; H Kuriyama
Journal:  J Physiol       Date:  1980-10       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.